About
Membrane Lipid Therapy, Synthetic Fatty Acids
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
241
By Phase
PHASE1/PHASE2: 2PHASE2/PHASE3: 1PHASE1: 1
By Status
COMPLETED: 2RECRUITING: 1ACTIVE_NOT_RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT04299191Lead Sponsor
Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors
PHASE1/PHASE2Recruiting
28 participants
Started: Sep 1, 2020 · Completed: Sep 30, 2025
NCT04250922Lead Sponsor
LAM561 With RT and TMZ for Adults With Glioblastoma
PHASE2/PHASE3Active, not recruiting
140 participants
Started: Dec 1, 2019 · Completed: May 30, 2025
NCT03867123Lead Sponsor
A Study to Evaluate the Safety of LAM561 Added to Standard of Care in Newly-diagnosed Glioblastoma Patients
PHASE1Completed
18 participants
Started: Dec 4, 2018 · Completed: Jul 1, 2020
NCT01792310Lead Sponsor
A Phase 1/2A Study of LAM561 in Adult Patients With Advanced Solid Tumours
PHASE1/PHASE2Completed
54 participants
Started: May 31, 2013 · Completed: Sep 30, 2016
NCT00840515Lead Sponsor
PraevoSkin Emulsion in the Prevention of Radiation Induced Dermatitis
N/AUnknown
1 participants
Started: Feb 28, 2009 · Completed: Aug 31, 2009
Locations (1)
Headquarters
Palma de Mallorca, Spain
Map
Loading map...